We found that miR-326 could suppress the expression and external secretion of TGF-β1 in GBM via the SMO/Gli2 signalling pathway, which could at least partially reduce the stress of immunosuppressive environment, and therefore enhance the effect of a DC vaccine. This evidence concerns the gene TGFB1 and glioblastoma.